CFDE Data Portal | Search FXYD4

	Label	Description
	FXYD4 associations Collection (Entity type)	Associations for FXYD4_associations
	FXYD4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FXYD4 Gene (Entity type)	ENSG00000150201 - FXYD domain containing ion transport regulator 4
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210655 1 V 0 CISPLATIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE171180,GSE171181 0 V 1 E7107 HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE158431 2 V 6 PIOGLITAZONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE60691 2 V 1 GLUTAMINE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

FXYD4 associations

Associations for FXYD4_associations

FXYD4 associations.tsv

A file from IDG as part of the Harmonizome project

FXYD4

ENSG00000150201 - FXYD domain containing ion transport regulator 4

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE210655 1 V 0 CISPLATIN MOUSE UP

A Gene Set from LINCS

GSE198930 prunetin AGS 1 v 0 human dn

A Gene Set from LINCS

GSE171180,GSE171181 0 V 1 E7107 HUMAN UP

A Gene Set from LINCS

GSE158431 2 V 6 PIOGLITAZONE MOUSE DN

A Gene Set from LINCS

GSE176008 pyridoxine 0 v 1 human dn

A Gene Set from LINCS

GSE60691 2 V 1 GLUTAMINE MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.